11/16
01:06 am
orka
Oruka Therapeutics (NASDAQ:ORKA) was downgraded by analysts at
Wall Stre
Low
Report
Oruka Therapeutics (NASDAQ:ORKA) was downgraded by analysts at
Wall Stre
11/15
04:40 am
orka
ORKA-001 Trial Progress and US$180 Million PIPE Financing Might Change The Case For Investing In Oruka Therapeutics (ORKA) [Yahoo! Finance]
Low
Report
ORKA-001 Trial Progress and US$180 Million PIPE Financing Might Change The Case For Investing In Oruka Therapeutics (ORKA) [Yahoo! Finance]
11/13
08:11 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its price target raised by analysts at BTIG Research from $56.00 to $63.00. They now have a "buy" rating on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) had its price target raised by analysts at BTIG Research from $56.00 to $63.00. They now have a "buy" rating on the stock.
11/13
08:11 am
orka
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $45.00 price target on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $45.00 price target on the stock.
11/13
12:43 am
orka
Oruka Therapeutics GAAP EPS of -$0.55 beats by $0.01 [Seeking Alpha]
Medium
Report
Oruka Therapeutics GAAP EPS of -$0.55 beats by $0.01 [Seeking Alpha]
11/12
04:53 pm
orka
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:05 pm
orka
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/29
07:00 am
orka
Oruka Therapeutics to Present at Multiple November Investor Conferences
Low
Report
Oruka Therapeutics to Present at Multiple November Investor Conferences
10/27
08:06 am
orka
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
10/27
08:05 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.
10/14
07:59 am
orka
Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
10/13
07:04 am
orka
Oruka Therapeutics (NASDAQ:ORKA) was given a new $48.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Low
Report
Oruka Therapeutics (NASDAQ:ORKA) was given a new $48.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
10/3
05:28 pm
orka
Oruka Therapeutics files to sell 39.43M shares of common stock for holders [Seeking Alpha]
Medium
Report
Oruka Therapeutics files to sell 39.43M shares of common stock for holders [Seeking Alpha]
9/29
08:05 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.
High
Report
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.
9/18
08:09 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its price target raised by analysts at BTIG Research from $44.00 to $56.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (NASDAQ:ORKA) had its price target raised by analysts at BTIG Research from $44.00 to $56.00. They now have a "buy" rating on the stock.
9/17
01:07 am
orka
Oruka Therapeutics Announces $180 Million Private Placement [Yahoo! Finance]
Low
Report
Oruka Therapeutics Announces $180 Million Private Placement [Yahoo! Finance]
9/17
01:07 am
orka
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001 [Yahoo! Finance]
Low
Report
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001 [Yahoo! Finance]
9/17
01:02 am
orka
Oruka Therapeutics Announces $180 Million Private Placement
Medium
Report
Oruka Therapeutics Announces $180 Million Private Placement
9/17
01:00 am
orka
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001
Medium
Report
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001